SCHEMBL6604994

SCHEMBL6604994

CC(C)N(CCOc1cccc(NC(=O)c2csc(-c3ccc(C(F)(F)F)cc3Cl)n2)c1)C(C)C

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NPSR1 Q6W5P4 2/20 0.55
MAPK1 P28482 2/20 0.49
IDE P14735 1/20 0.49
MAPK10 P53779 1/20 0.49
MAPT P10636 5/20 0.48
KDM4E B2RXH2 2/20 0.48
NR1H4 Q96RI1 1/20 0.47
MCHR1 Q99705 3/20 0.46
POLB P06746 2/20 0.44
HTT P42858 1/20 0.44
IRAK4 Q9NWZ3 1/20 0.42
LMNA P02545 2/20 0.42
GAA P10253 2/20 0.41
ALDH1A1 P00352 2/20 0.41
EPHX2 P34913 1/20 0.41
TLR7 Q9NYK1 1/20 0.40
MEN1 O00255 1/20 0.40
HPGD P15428 1/20 0.40
KMT2A Q03164 1/20 0.40
ATM Q13315 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6605001 0.89 NPSR1 (0.55) NPSR1MAPK1IDEMAPK10MAPT
SCHEMBL6604053 0.89 MAPK1 (0.57) NPSR1MAPK1IDEMAPK10MAPT
SCHEMBL6603055 0.86 MCHR1 (0.58) NPSR1MAPK1IDEMAPK10MAPT
SCHEMBL6603342 0.85 PANK3 (0.53) NPSR1MAPTKDM4EMCHR1IRAK4
SCHEMBL6604027 0.82 MAPT (0.58) NPSR1MAPK1IDEMAPK10MAPT
SCHEMBL6604067 0.81 IRAK4 (0.56) NPSR1MAPK1IDEMAPK10MAPT
SCHEMBL6603701 0.79 IRAK4 (0.45) NPSR1MAPK1IDEMAPK10MAPT
SCHEMBL6607004 0.79 IRAK4 (0.45) NPSR1MAPTKDM4EMCHR1IRAK4
SCHEMBL6604059 0.77 MAPK1 (0.57) NPSR1MAPK1IDEMAPK10MAPT
SCHEMBL6602613 0.77 MCHR1 (0.66) MAPK1IDEMAPK10MAPTKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1102535-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-09-29 EP claimed
EP-1102535-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2001-05-30 EP claimed
WO-2000006085-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO claimed
EP-1102535-A4 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORP (US) 2004-09-29 EP disclosed
US-6399656-B1 USING A BENZOPYRAN-3-CARBOXAMIDE COMPOUND SMITHKLINE BEECHAM CORPORATION 2002-06-04 US disclosed
EP-1102535-A2 COMPOUNDS AND METHODS SmithKline Beecham Corporation (US) 2001-05-30 EP disclosed
WO-2000006085-A2 COMPOUNDS AND METHODS SMITHKLINE BEECHAM CORPORATION (US) 2000-02-10 WO disclosed